Press Release: Cycurion Beats Consensus on Revenue and EPS; Gross Margin Improves Nearly 5x as Company Positions for Stronger Second Half

Dow Jones
08/14

MCLEAN, Va., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. $(CYCU)$ ("Cycurion" or the "Company"), a leader in AI-driven cybersecurity, national security, and public safety technology solutions, today announced financial results for the second quarter ended June 30, 2026.

Second Quarter 2026 Highlights

   -- Revenue of $3.8 million, exceeding Wall Street consensus of $3.62 million 
      (essentially flat versus $3.9 million in the second quarter of 2025) 
 
   -- Gross profit of $1.1 million (29.1% gross margin), a nearly five-fold 
      increase from $0.2 million (6.1% margin) in the prior-year period 
 
   -- EPS of $(0.41), beating consensus of $(0.56); net loss of $(4.0) million, 
      improved from $(5.3) million in the second quarter of 2025 
 
   -- Adjusted EBITDA of $(1.4) million, improved from $(2.1) million in the 
      prior-year quarter 
 
   -- Net debt dropped 28% to $5.8 million from $8.1 million year-over-year 

"The second quarter represents a historic turning point for Cycurion," said Kevin Kelly, Chairman and Chief Executive Officer. "We beat Wall Street estimates on both revenue and earnings, gross margins expanded dramatically and we secured the largest contract in Company history while closing transformative acquisitions. Reaching an estimated $30 million revenue run rate validates our strategic vision. Our new $54.6 million, 10-year contract with a global consulting firm, together with the acquisitions of Secuvant and Kustom's video solutions, provide strong, visible cash flows. We are deliberately shifting toward higher-margin cybersecurity, managed services, and strategic consulting across federal, state, and local government markets."

Strategic and Operational Momentum

Largest Contract in Company History

In July 2026, Cycurion secured a $54.6 million, 10-year award with a global consulting firm to modernize and securely operate a major Health and Human Services system for a state government agency. The agreement is expected to generate more than $5 million in annual recurring revenue, with work scheduled to commence in November 2026.

Transformative Acquisitions

The acquisitions of Secuvant, LLC and Kustom Entertainment Inc.'s video solutions business significantly expand Cycurion's capabilities, customer base, and addressable market. These transactions create meaningful cross-selling opportunities across government, enterprise, and public safety customers and contribute to the Company's estimated $30 million revenue run rate.

Accelerating Government Momentum

Cycurion continues to expand aggressively across federal, state, and local government markets:

   -- State & Local Government: Pursuing multi-year awards representing 
      approximately $5 million in potential contract revenue (including $1.8 
      million in potential first-year revenue). Key initiatives include 
      AI-enhanced CAD/911 public safety systems, cybersecurity assessments for 
      a major tollway authority, and health and human services modernization. 
 
   -- Federal Government: Generated more than $500,000 in network 
      infrastructure services revenue year-to-date and expects to reach 
      approximately $1 million for full-year 2026. Current work includes VoIP 
      implementation for a large federal agency and ongoing networking and 
      cybersecurity infrastructure support across multiple federal customers. 
 
   -- Statewide Term Contracts & MSAs: Actively pursuing Master Services 
      Agreements and IDIQ vehicles with a major U.S. municipality and the 
      states of Florida, Illinois, Vermont, and North Carolina. These 
      multi-year vehicles position Cycurion to deliver organizational 
      management, cybersecurity, internal audit, data analytics, and IT 
      solutions on an as-needed basis. 

Robust Sales Pipeline

As of early August 2026, Cycurion is actively pursuing 122 open opportunities representing approximately $34 million in potential additional first-year contract value, including approximately $11 million in late-stage pursuits. The Company has already closed 41 new awards year-to-date in 2026, building a growing base of long-term contracts and expanding relationships within existing customers.

Cost Discipline and Balance Sheet Strength

Cycurion continues to execute cost-reduction initiatives expected to generate more than $2.2 million in annualized savings, with meaningful benefits already reflected in first-half 2026 results. Combined with a 28% reduction in net debt, the Company enters the second half of 2026 with improved operating leverage and a strengthened balance sheet.

Outlook

Cycurion enters the second half of 2026 from a position of strength, with significantly increased revenue visibility and a clear path to higher contribution from recent wins. The third quarter is already off to a strong start, supported by record-breaking new contracts that commenced late in the second quarter of 2026 or are scheduled to begin throughout the remainder of 2026. The Company's landmark $54.6 million contract is set to commence in November, providing visible recurring revenue in the fourth quarter, while the acquisitions of Secuvant, LLC and Kustom Entertainment Inc.'s video solutions business continue to expand the customer base and contribute to the estimated $30 million revenue run rate. Combined with ongoing cost controls and a robust pipeline of 122 opportunities, management expects these factors to support improved operating performance in the second half of 2026 and into 2027. The Company remains focused on disciplined execution, profitable growth, and delivering long-term value for shareholders.

About Cycurion

Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.

About Secuvant

Secuvant is an independent IT security firm providing enterprise-grade cybersecurity services, risk management, and managed solutions to mid-market organizations. Founded in 2014, it specializes in managed security services, threat and vulnerability management and compliance using its Cyber7$(TM)$ framework. For more information, visit www.secuvant.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion's business.

Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction contemplated by the binding agreement, including the likelihood, timing, structure or consummation of the transaction; the anticipated benefits of the transaction; the acceleration of the Company's inorganic growth strategy; the continued execution on the Company's backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, risks related to customer performance and satisfaction, contract modifications, delays or terminations, and the Company's ability to fulfill contractual obligations, the outcomes of the Company's investigations, any potential legal proceedings, or the future performance of the Company's stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion's plans and expectations as of any subsequent date.

Non-GAAP Financial Measures

This release includes non-GAAP financial measures (EBITDA and Adjusted EBITDA). These measures are provided for supplemental informational purposes only and should not be considered substitutes for GAAP results. A reconciliation of net loss to EBITDA and Adjusted EBITDA is included in the Company's full earnings materials filed with the SEC.

In addition to our results determined in accordance with U.S. GAAP, we believe the non-GAAP financial measures of EBITDA, and Adjusted EBITDA are useful in evaluating our operating performance. We believe that this non-GAAP financial information, when taken collectively with our GAAP results, may be helpful to readers of our financial statements because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results. The non-GAAP financial information is presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly-titled non-GAAP measures used by other companies. A reconciliation is provided below for each of these non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Cycurion believes that EBITDA and Adjusted EBITDA provide the Board of Directors, management and investors with a clear representation of the Company's core operating performance and trends, provide greater visibility into the long-term financial performance of the Company, and eliminate the impact of items that do not relate to the ongoing operating performance of the business. Cycurion believes these non-GAAP financial measures facilitate the comparison of the Company's operating performance on a consistent basis between periods by excluding certain items that may, or could, have a disproportionately positive or negative impact on the Company's results of operations in any particular period. When viewed in combination with the Company's results prepared in accordance with GAAP, these non-GAAP financial measures help provide a broader picture of factors and trends affecting the Company's results of operations. EBITDA and Adjusted EBITDA are supplemental measures of operating performance that are not made under GAAP and do not represent, and should not be considered as an alternative to net (loss)/income, earnings per share or operating expenses, as determined by GAAP. The Company defines EBITDA as net (loss)/income, adjusted for interest expense, provision for/(benefit from) income taxes, and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, adjusted for stock-based compensation expense, gain/(loss) on debt settlement, acquisition and transaction costs and other one-time expenses that are not part of the normal operating activities.

EBITDA and Adjusted EBITDA each has limitations as an analytical tool, and you should not consider any of them in isolation, or as a substitute for analysis of results as reported under GAAP. Other companies in the Company's industry may calculate Adjusted EBITDA differently than Cycurion does, which limits its usefulness as a comparative measure. Because of these limitations, neither EBITDA or Adjusted EBITDA should be considered as a replacement for net (loss)/income, or as a measure of profitability. Cycurion compensates for these limitations by relying primarily on the Company's GAAP results and using non-GAAP measures only for supplemental purposes.

Cycurion Investor Relations:

(888) 341-6680

investors@cycurion.com

Cycurion Media Relations:

(888) 341-6680

media@cycurion.com

 
       Quarterly Results of Operations and Non-GAAP Financial 
                              Measures 
                            (Unaudited) 
 
Quarterly Consolidated Results of Operations 
-------------------------------------------------------------------- 
                              For the Three Months Ended 
                   ------------------------------------------------- 
                    June 30, 2026   March 31, 2026    June 30, 2025 
                   ---------------  ---------------  --------------- 
Revenue            $ 3,757,076      $ 3,268,620      $ 3,887,915 
Cost of revenue      2,663,739        2,580,262        3,651,978 
                    ----------       ----------       ---------- 
  Gross profit       1,093,337          688,358          235,937 
  Gross margin            29.1%            21.1%             6.1% 
Operating 
expenses: 
  Selling, 
   general and 
   administrative 
   expenses          2,641,320        2,743,695        2,313,343 
  Stock 
   compensation 
   expenses            336,722          315,833        1,012,443 
  Business 
   combination 
   expenses                 --               --          676,228 
                    ----------       ----------       ---------- 
  Total operating 
   expenses          2,978,042        3,059,528        4,002,014 
                    ----------       ----------       ---------- 
  Operating loss    (1,884,705)      (2,371,170)      (3,766,077) 
  Interest income        3,506           14,236               -- 
  Interest 
   expense            (227,941)        (204,852)        (615,392) 
  Loss on debt 
   settlement, 
   net              (1,930,427)              --         (907,983) 
  Other expense             --               --             (962) 
                    ----------       ----------       ---------- 
Other expense, 
 net                (2,154,862)        (190,616)      (1,524,337) 
                    ----------       ----------       ---------- 
  Loss before 
   income taxes     (4,039,567)      (2,561,786)      (5,290,414) 
                    ----------       ----------       ---------- 
Provision for 
income tax                  --               --               -- 
                    ----------       ----------       ---------- 
  Net loss          (4,039,567)      (2,561,786)      (5,290,414) 
                    ----------       ----------       ---------- 
Less: Net loss 
 attributable to 
 non-controlling 
 interest              283,793          433,324          101,659 
                    ----------       ----------       ---------- 
  Net loss 
   attributable 
   to Cycurion     $(3,755,774)     $(2,128,462)     $(5,188,755) 
                    ----------       ----------       ---------- 
 
 
Quarterly Reconciliation of Net Loss to EBITDA (Non-GAAP) 
 and Adjusted EBITDA (Non-GAAP) 
---------------------------------------------------------------------- 
                               For the Three Months Ended 
                  ---------------------------------------------------- 
                   June 30, 2026    March 31, 2026     June 30, 2025 
                  ---------------  ----------------  ----------------- 
Net loss           $  (4,039,567)   $   (2,561,786)   $  (5,290,414) 
  Interest 
   income                 (3,506)          (14,236)              -- 
  Interest 
   expense               227,941           204,852          615,392 
  Depreciation 
   and 
   amortization               --                --           10,530 
                      ----------       -----------       ---------- 
EBITDA 
 (Non-GAAP)           (3,815,132)       (2,371,170)      (4,664,492) 
  Loss on debt 
   settlement, 
   net (1)             1,930,427                --          907,983 
  Transaction 
   related 
   expenses (2)           75,237                --          676,228 
  One-time 
  expenses (3)            90,000                --               -- 
  Stock 
   compensation 
   expenses (4)          336,722           315,833        1,012,443 
                      ----------       -----------       ---------- 
Adjusted EBITDA 
 (Non-GAAP)        $  (1,382,746)   $   (2,055,337)   $  (2,067,838) 
                      ==========       ===========       ========== 
 
 
      (1)  Loss on debt settlement, net represents the conversion 
            of the promissory notes primarily related to the deemed 
            issuance cost of preferred stock issued to satisfy 
            default interest obligations. 
      (2)  Acquisition and transaction/business combination costs 
            generally represent professional fees and direct expenses 
            related to acquisitions and public offerings. 
      (3)  One-time expenses represent non-ordinary course costs 
            in connection with a change in a contract or a change 
            in the makeup of our personnel often related to an 
            acquisition, such as severance payments, recruiting 
            fees and retention charges. 
      (4)  Stock compensation expense represents a portion of 
            compensation paid to our employees and executives 
            through stock-based instruments. 
 
 
                   CYCURION, INC. AND SUBSIDIARIES 
                     CONSOLIDATED BALANCE SHEETS 
                             (Unaudited) 
 
                                          June 30,      December 31, 
                                             2026            2025 
                                        -------------  --------------- 
Assets: 
  Cash and cash equivalents             $  1,873,287   $  5,255,235 
  Accounts receivable, net                 3,721,520      2,687,479 
  Prepaid expenses and other current 
   assets                                    222,886         60,133 
  Other receivables                          133,058             -- 
                                         -----------    ----------- 
    Total current assets                   5,950,751      8,002,847 
  Software development costs, net          4,798,981      4,606,981 
  Goodwill and intangibles                27,617,398     20,842,508 
                                         -----------    ----------- 
    Total non-current assets              32,416,379     25,449,489 
                                         -----------    ----------- 
      Total assets                      $ 38,367,130   $ 33,452,336 
                                         ===========    =========== 
Liabilities and Stockholders' Equity: 
Liabilities: 
  Bank loan-revolving credit line       $  2,421,305   $  2,933,396 
  Loans payable - current portion            269,068        669,693 
  Factoring liability                      1,300,470      1,511,678 
  Convertible notes                        2,686,748        192,897 
  Promissory notes                         1,161,960      2,499,662 
  Loans payable - related parties            123,650        123,650 
  Accounts payable                         1,290,801      1,314,772 
  Accrued liabilities                      7,613,943      4,228,337 
  Accrued compensation and benefits        1,063,856        919,825 
  Accrued interest payable                   432,748      1,347,787 
  Excise tax payable                       1,167,173      1,167,173 
                                         -----------    ----------- 
    Total current liabilities             19,531,722     16,908,870 
  Loans payable - non-current portion        627,010        300,000 
                                         -----------    ----------- 
    Total non-current liabilities            627,010        300,000 
                                         -----------    ----------- 
      Total liabilities                   20,158,732     17,208,870 
Stockholders' Equity: 
  Preferred stock ($0.0001 par value, 20,000,000 shares 
   authorized) 
  Series A convertible preferred stock 
  ($0.0001 par value, 110,000 shares 
  designated, 0 and 0 issued and 
  outstanding, respectively)                      --             -- 
  Series B convertible preferred stock 
  ($0.0001 par value, 3,000 shares 
  designated, 0 and 1 issued and 
  outstanding, respectively)                      --             -- 
  Series C convertible preferred stock 
  ($0.0001 par value, 5,000 shares 
  designated, 2,547 and 4,851 issued 
  and outstanding, respectively)                  --             -- 
  Series D convertible preferred stock 
   ($0.0001 par value, 6,666,700 
   shares designated, 150,000 and 
   150,000 issued and outstanding, 
   respectively)                                  15             15 
  Series E convertible preferred stock 
  ($0.0001 par value, 100 shares 
  designated, 51 and 51 issued and 
  outstanding, respectively)                      --             -- 
  Series F convertible preferred stock 
  ($0.0001 par value, 10,000 shares 
  designated, 0 and 0 issued and 
  outstanding, respectively)                      --             -- 
  Series G convertible preferred stock 
  ($0.0001 par value, 10,000 shares 
  designated, 143 and 143 issued and 
  outstanding, respectively)                      --             -- 
  Series H convertible preferred stock 
  ($0.0001 par value, 10,000 shares 
  designated, 1,900 and 0 issued and 
  outstanding, respectively)                      --             -- 
  Series I convertible preferred stock 
  ($0.0001 par value, 888,888 shares 
  designated, 888,888 and 0 issued and 
  outstanding, respectively)                      89             -- 
  Common stock ($0.0001 par value, 
   300,000,000 shares authorized, 
   11,889,767 and 3,642,501 shares 
   issued and outstanding, 
   respectively)                               1,189            364 
  Additional paid in capital              55,545,133     46,979,762 
  Accumulated deficit                    (32,763,317)   (26,879,081) 
                                         -----------    ----------- 
    Total stockholders' equity 
     attributable to Cycurion             22,783,109     20,101,060 
                                         -----------    ----------- 
    Deficit attributable to 
     noncontrolling interests             (4,574,711)    (3,857,594) 
      Total stockholders' equity          18,208,398     16,243,466 
                                         -----------    ----------- 
     Total liabilities and 
      stockholders' equity              $ 38,367,130   $ 33,452,336 
                                         ===========    =========== 
 
 
                         CYCURION, INC. AND SUBSIDIARIES 
             CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE 
                                       LOSS 
                                   (Unaudited) 
 
                      For the Three Months Ended    For the Six Months Ended June 
                               June 30,                          30, 
                     -----------------------------  ----------------------------- 
                          2026            2025          2026           2025 
                     ---------------  ------------  ------------  --------------- 
Revenue              $ 3,757,076      $ 3,887,915   $ 7,025,696   $  7,757,965 
Cost of revenue        2,663,739        3,651,978     5,244,001      6,844,265 
                      ----------       ----------    ----------    ----------- 
  Gross profit         1,093,337          235,937     1,781,695        913,700 
Operating expenses: 
    Selling, 
     general and 
     administrative 
     expenses          2,641,320        2,313,343     5,385,015      2,650,716 
    Stock 
     compensation 
     expenses            336,722        1,012,443       652,555      1,012,443 
    Business 
     combination 
     expenses                 --          676,228            --     11,114,122 
                      ----------       ----------    ----------    ----------- 
  Total operating 
   expenses            2,978,042        4,002,014     6,037,570     14,777,281 
                      ----------       ----------    ----------    ----------- 
Operating loss        (1,884,705)      (3,766,077)   (4,255,875)   (13,863,581) 
  Other income/(expenses): 
   Interest income         3,506               --        17,742             -- 
   Interest expense     (227,941)        (615,392)     (432,793)      (794,283) 
   Loss on debt 
    settlement, 
    net               (1,930,427)        (907,983)   (1,930,427)      (766,330) 
   Other expense, 
    net                       --             (962)           --       (114,706) 
                      ----------       ----------    ----------    ----------- 
Other expenses, net   (2,154,862)      (1,524,337)   (2,345,478)    (1,675,319) 
                      ----------       ----------    ----------    ----------- 
     Loss before 
      income taxes    (4,039,567)      (5,290,414)   (6,601,353)   (15,538,900) 
                      ----------       ----------    ----------    ----------- 
Provision for 
income tax                    --               --            --             -- 
                      ----------       ----------    ----------    ----------- 
     Net loss         (4,039,567)      (5,290,414)   (6,601,353)   (15,538,900) 
                      ==========       ==========    ==========    =========== 
Less: Net loss 
 attributable to 
 non-controlling 
 interest                283,793          101,659       717,117        101,659 
                      ----------       ----------    ----------    ----------- 
     Net loss 
      attributable 
      to Cycurion    $(3,755,774)     $(5,188,755)  $(5,884,236)  $(15,437,241) 
                      ==========       ==========    ==========    =========== 
 
     Comprehensive 
      loss           $(3,755,774)     $(5,188,755)  $(5,884,236)  $(15,437,241) 
                      ==========       ==========    ==========    =========== 
 
Loss per share: 
   Basic             $     (0.41)     $     (4.31)  $     (0.86)  $     (16.55) 
   Diluted           $     (0.41)     $     (3.38)  $     (0.86)  $     (16.45) 
Weighted average shares outstanding: 
   Basic               9,065,675        1,204,462     6,826,267        932,849 
   Diluted             9,065,675        1,532,549     6,826,267        936,209 
 
 
                    CYCURION, INC. AND SUBSIDIARIES 
                 CONSOLIDATED STATEMENTS OF CASH FLOWS 
                              (Unaudited) 
 
                                    For the Six Months Ended June 30, 
                                 --------------------------------------- 
                                        2026                 2025 
                                 -------------------  ------------------ 
Cash flows from operating activities: 
  Net loss                        $      (6,601,353)  $   (15,538,900) 
  Adjustments to reconcile net loss to net cash used 
   in operating activities: 
    Stock compensation expenses             652,555         1,284,777 
    Stock-based compensation - 
     business combination 
     related                                      -         9,250,000 
    Amortization of debt 
     discount                                 1,187           213,036 
    Depreciation of property 
     and equipment                                -             3,489 
    Amortization of software 
     development costs                            -            17,083 
    Loss on debt settlement, 
     net                                  1,930,427           766,330 
    Finance expense                               -           100,000 
    Changes in assets and liabilities: 
      Accounts receivable, net 
       and other receivables             (1,010,583)       (1,478,433) 
      Prepaid expenses and 
       other current assets                 (61,498)           45,204 
      Accounts payable and 
       accrued liabilities               (1,221,050)         (738,998) 
      Accrued compensation and 
       benefits                            (111,386)          (17,042) 
      Accrued interest payable              247,525          (209,668) 
                                     --------------    -------------- 
      Net cash used in 
       operating activities              (6,174,176)       (6,303,122) 
                                     --------------    -------------- 
Cash flows from investing activities: 
  Net cash acquired on business 
   combination                              208,014            34,983 
  Capitalized software 
   development costs                       (192,000)         (174,000) 
  Cash withdrawn from Trust 
   Account in connection with 
   redemption                                     -         1,001,216 
  Release of Trust Account to 
   Company's bank account                         -           833,324 
                                     --------------    -------------- 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10